FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087636411> ?p ?o ?g. }

• W2087636411 endingPage "122" @default.
• W2087636411 startingPage "112" @default.
• W2087636411 abstract "The effects of a synthetic oral progestogen, desogestrel (DSG), administered with low dose testosterone (T) were investigated to determine the optimal combination for suppression of gonadotropins and spermatogenesis to targets compatible with effective male contraception. Twenty-four healthy male volunteers (33.2 +/- 0.9 yr) were randomly assigned to 3 groups (n = 8) to receive: 1) 300 microg DSG orally daily and 100 mg T enanthate, i.m., weekly; 2) 300 microg DSG and 50 mg T enanthate; or 3) 150 microg DSG and 100 mg T enanthate for 24 weeks. To investigate the individual contribution to the combined action, DSG was administered alone for the first 3 weeks, and T enanthate was added on day 22. After 24-week treatment, sperm density in 78% (18 of 23) of the subjects became azoospermic, whereas 91.7% (22 of 24) and 95.8% (23 of 24) suppressed to less than 1 million/mL and less than 3 million/mL, respectively. The 300 microg DSG with 50 mg T enanthate combination induced azoospermia in 8 of 8 subjects, and the suppression of sperm density was significantly greater than that in the 300 microg DSG/100 mg T enanthate group, but was not different from that in the 150 microg DSG/100 mg T enanthate group. DSG (300 or 150 microg daily) alone in the first 3 weeks suppressed LH, FSH, and T to 60.6%, 48.0%, and 35.4%, respectively, of the baseline. Addition of T enanthate (50 and 100 mg weekly) raised plasma T to the physiological range and induced a further fall in LH and FSH to the limits of assay detection. There was no consistent difference in mean LH and FSH levels among the three groups during treatment or recovery, except that FSH remained detectable in a higher proportion of samples from the group receiving 300 microg DSG with 50 mg T enanthate. Total cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol decreased by 9.3 +/- 1.7%, 10.3 +/- 2.6%, and 7.7 +/- 2.8%, respectively, during treatment with DSG alone with no difference between 300 and 150 microg. Addition of T enanthate (both 50 and 100 mg weekly) induced a further fall only in high density lipoprotein cholesterol to 22.6 +/- 3.7% from the baseline. In summary, the combined actions of oral DSG with low doses of T enanthate were highly effective in suppressing pituitary-testicular functions in adult men. The optimal regimen for inducing azoospermia was 300 microg DSG daily with 50 mg T enanthate weekly. Oral DSG exerted discernible effects on lipid metabolism. We conclude that the combination of oral progestogens with low dose T is a promising approach to achieve effective reversible male contraception." @default.
• W2087636411 created "2016-06-24" @default.
• W2087636411 creator A5031554466 @default.
• W2087636411 creator A5034339891 @default.
• W2087636411 creator A5056068375 @default.
• W2087636411 creator A5065682345 @default.
• W2087636411 date "1999-01-01" @default.
• W2087636411 modified "2023-10-07" @default.
• W2087636411 title "Oral Progestogen Combined with Testosterone as a Potential Male Contraceptive: Additive Effects between Desogestrel and Testosterone Enanthate in Suppression of Spermatogenesis, Pituitary-Testicular Axis, and Lipid Metabolism1" @default.
• W2087636411 cites W10772529 @default.
• W2087636411 cites W1536008013 @default.
• W2087636411 cites W1965974986 @default.
• W2087636411 cites W1966232669 @default.
• W2087636411 cites W1966422537 @default.
• W2087636411 cites W1973022634 @default.
• W2087636411 cites W1974466802 @default.
• W2087636411 cites W1982300784 @default.
• W2087636411 cites W1989963197 @default.
• W2087636411 cites W1994440984 @default.
• W2087636411 cites W2000992161 @default.
• W2087636411 cites W2001102039 @default.
• W2087636411 cites W2008329556 @default.
• W2087636411 cites W2010392278 @default.
• W2087636411 cites W2027137035 @default.
• W2087636411 cites W2033583816 @default.
• W2087636411 cites W2033775177 @default.
• W2087636411 cites W2036731286 @default.
• W2087636411 cites W2041694702 @default.
• W2087636411 cites W2044254503 @default.
• W2087636411 cites W2045760009 @default.
• W2087636411 cites W2046800613 @default.
• W2087636411 cites W2051494151 @default.
• W2087636411 cites W2061438670 @default.
• W2087636411 cites W2062895247 @default.
• W2087636411 cites W2064993444 @default.
• W2087636411 cites W2069535565 @default.
• W2087636411 cites W2070568921 @default.
• W2087636411 cites W2079205186 @default.
• W2087636411 cites W2080911773 @default.
• W2087636411 cites W2088416370 @default.
• W2087636411 cites W2088451062 @default.
• W2087636411 cites W2091414980 @default.
• W2087636411 cites W2112016810 @default.
• W2087636411 cites W2126587448 @default.
• W2087636411 cites W2145469354 @default.
• W2087636411 cites W2150150420 @default.
• W2087636411 cites W2163131244 @default.
• W2087636411 cites W2167105346 @default.
• W2087636411 cites W2344878025 @default.
• W2087636411 cites W2411392514 @default.
• W2087636411 cites W2615609643 @default.
• W2087636411 cites W2622606963 @default.
• W2087636411 doi "https://doi.org/10.1210/jcem.84.1.5412" @default.
• W2087636411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9920070" @default.
• W2087636411 hasPublicationYear "1999" @default.
• W2087636411 type Work @default.
• W2087636411 sameAs 2087636411 @default.
• W2087636411 citedByCount "36" @default.
• W2087636411 countsByYear W20876364112013 @default.
• W2087636411 countsByYear W20876364112016 @default.
• W2087636411 countsByYear W20876364112019 @default.
• W2087636411 crossrefType "journal-article" @default.
• W2087636411 hasAuthorship W2087636411A5031554466 @default.
• W2087636411 hasAuthorship W2087636411A5034339891 @default.
• W2087636411 hasAuthorship W2087636411A5056068375 @default.
• W2087636411 hasAuthorship W2087636411A5065682345 @default.
• W2087636411 hasBestOaLocation W20876364111 @default.
• W2087636411 hasConcept C123765429 @default.
• W2087636411 hasConcept C126322002 @default.
• W2087636411 hasConcept C134018914 @default.
• W2087636411 hasConcept C2777420699 @default.
• W2087636411 hasConcept C2777688143 @default.
• W2087636411 hasConcept C2779076696 @default.
• W2087636411 hasConcept C2779234561 @default.
• W2087636411 hasConcept C2779279991 @default.
• W2087636411 hasConcept C2779441745 @default.
• W2087636411 hasConcept C2780099242 @default.
• W2087636411 hasConcept C2780572241 @default.
• W2087636411 hasConcept C2908647359 @default.
• W2087636411 hasConcept C2986817661 @default.
• W2087636411 hasConcept C54355233 @default.
• W2087636411 hasConcept C71315377 @default.
• W2087636411 hasConcept C71924100 @default.
• W2087636411 hasConcept C86803240 @default.
• W2087636411 hasConcept C99454951 @default.
• W2087636411 hasConceptScore W2087636411C123765429 @default.
• W2087636411 hasConceptScore W2087636411C126322002 @default.
• W2087636411 hasConceptScore W2087636411C134018914 @default.
• W2087636411 hasConceptScore W2087636411C2777420699 @default.
• W2087636411 hasConceptScore W2087636411C2777688143 @default.
• W2087636411 hasConceptScore W2087636411C2779076696 @default.
• W2087636411 hasConceptScore W2087636411C2779234561 @default.
• W2087636411 hasConceptScore W2087636411C2779279991 @default.
• W2087636411 hasConceptScore W2087636411C2779441745 @default.
• W2087636411 hasConceptScore W2087636411C2780099242 @default.
• W2087636411 hasConceptScore W2087636411C2780572241 @default.
• W2087636411 hasConceptScore W2087636411C2908647359 @default.
• W2087636411 hasConceptScore W2087636411C2986817661 @default.

• next